ROYAL BANK OF CANADA - ALLOVIR INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALLOVIR INC
ValueSharesWeighting
Q3 2023$18,000
+20.0%
8,547
+95.4%
0.00%
Q2 2023$15,000
+87.5%
4,374
+107.7%
0.00%
Q1 2023$8,000
-55.6%
2,106
-40.8%
0.00%
Q4 2022$18,000
+500.0%
3,555
+833.1%
0.00%
Q3 2022$3,000
+50.0%
381
-19.8%
0.00%
Q2 2022$2,000
-85.7%
475
-77.5%
0.00%
Q1 2022$14,000
-83.5%
2,112
-67.8%
0.00%
Q4 2021$85,000
+16.4%
6,559
+126.2%
0.00%
Q3 2021$73,000
+52.1%
2,900
+17.3%
0.00%
Q2 2021$48,000
-14.3%
2,472
+4.7%
0.00%
Q1 2021$56,000
+124.0%
2,362
+260.6%
0.00%
Q4 2020$25,000
-94.3%
655
-95.9%
0.00%
Q3 2020$436,00015,8500.00%
Other shareholders
ALLOVIR INC shareholders Q4 2023
NameSharesValueWeighting ↓
Artal Group S.A. 2,323,371$63,893,0001.55%
Redmile Group, LLC 2,333,390$64,168,0001.18%
Woodline Partners LP 1,191,014$32,753,0001.07%
EcoR1 Capital, LLC 447,012$12,293,0000.88%
Samsara BioCapital, LLC 91,057$2,504,0000.70%
SECTORAL ASSET MANAGEMENT INC 277,795$7,639,0000.66%
CNA FINANCIAL CORP 10,745$295,0000.11%
Marshall Wace North America L.P. 580,880$15,974,0000.10%
MIRABELLA FINANCIAL SERVICES LLP 16,791$462,0000.06%
Alkeon Capital Management 1,097,000$30,167,0000.06%
View complete list of ALLOVIR INC shareholders